In the past, chemotherapy treatment was given to patients based on where in the body the cancer began, not taking in the factors of the molecular diversity of the individual patient’s cancer. Over the years, the development and advancement of the treatment for cancer has improved by applying molecular testing to determine individual patient tumors through DNA, RNA, and proteins.
As explained in a new article, “Precision medicine targets molecular features in cancer cells that are not in normal cells and it is now a focus of drug development,” says Timothy Cannon, MD, Director, Molecular Tumor Board Program and Co-Director, Gastrointestinal Cancer Program at the Inova Schar Cancer Institute. New strategies that modernize clinical trials and allow multiple drugs to be tested simultaneously have helped make progress with successful individualized treatment in cancer care.
Read the full article: “A Look at The Future of Targeted Therapy”
FDA-approved technology helps surgeons visualize ovarian cancer in real time during surgery FAIRFAX, Va. –…
Leesburg, VA — Inova Loudoun Hospital Mobile Health Services will be providing countywide blood pressure…
Study at a glanceInova’s incidental lung nodule program has shown a 76% reduction in time…
Catherine Wymer, PharmD, is a senior clinical pharmacist at Inova 360° Concierge Medicine. As a…
Multidisciplinary pulmonary expertise supports diagnostic evaluation, treatment planning and longitudinal care Advanced lung disease and…
Heart failure is a major focus for Inova Schar Heart and Vascular’s care transformation efforts.…